--- title: "3 Best Stocks to Buy Today, 6/9/2026, According to Top Analysts" type: "News" locale: "en" url: "https://longbridge.com/en/news/289212923.md" description: "Top Wall Street analysts recommend three strong buy stocks: Verastem (VSTM), Seaport Therapeutics (SPTX), and Evolv Technologies Holdings (EVLV). Mizuho maintains a Buy on VSTM with a $14 target, implying 309.7% upside. Stifel maintains a Buy on SPTX with a $30 target, implying 100.3% upside. TD Cowen maintains a Buy on EVLV with a $10 target, implying 68.9% upside. All covered analysts recently rated these stocks as Buys." datetime: "2026-06-09T15:29:07.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/289212923.md) - [en](https://longbridge.com/en/news/289212923.md) - [zh-HK](https://longbridge.com/zh-HK/news/289212923.md) --- # 3 Best Stocks to Buy Today, 6/9/2026, According to Top Analysts Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well. ### Introducing TipRanks MCP for Agents - Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools. - Designed for personal research, portfolio monitoring, and AI-assisted investment workflows. To find more stocks like these, take a look at TipRanks' Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. Here are today's top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio. **Verastem (VSTM)** – Verastem is a biotech company that develops new drugs for cancer patients. Today, Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on the stock with a price target of $14 per share. In the last three months, all five Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 309.70%. **Seaport Therapeutics (SPTX)** – This is a biotech firm that is developing new drugs for depression, anxiety, and other brain disorders. Today, Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on the stock with a price target of $30 per share. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 100.34%. **Evolv Technologies Holdings (EVLV)** – This company provides artificial intelligence (AI)-based touchless security screening systems. Today, TD Cowen analyst Shaul Eyal maintained a Buy rating on the stock with a price target of $10 per share. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 68.89%. ### Related Stocks - [EVLV.US](https://longbridge.com/en/quote/EVLV.US.md) - [SPTX.US](https://longbridge.com/en/quote/SPTX.US.md) - [VSTM.US](https://longbridge.com/en/quote/VSTM.US.md) - [MFG.US](https://longbridge.com/en/quote/MFG.US.md) - [8411.JP](https://longbridge.com/en/quote/8411.JP.md) - [SF.US](https://longbridge.com/en/quote/SF.US.md) - [TD.US](https://longbridge.com/en/quote/TD.US.md) - [EVLVW.US](https://longbridge.com/en/quote/EVLVW.US.md) - [SF-C.US](https://longbridge.com/en/quote/SF-C.US.md) - [SFB.US](https://longbridge.com/en/quote/SFB.US.md) - [SF-B.US](https://longbridge.com/en/quote/SF-B.US.md) - [SF-D.US](https://longbridge.com/en/quote/SF-D.US.md) ## Related News & Research - [Seaport Therapeutics Q2 FY26 net loss widens to $62.6 million; R&D expenses rise to $24.62 million](https://longbridge.com/en/news/294682349.md) - [Verastem Stock Jumps As Data Shows Strong Survival Trends In Pancreatic Cancer](https://longbridge.com/en/news/290083508.md) - [17:23 ETArmor Launches Sovereign AI: A whole-company AI work platform for regulated industries](https://longbridge.com/en/news/294418838.md) - [08:46 ETReach3 Insights Launches AI Listening to Help Brands Understand How Generative AI Makes Brand Product Recommendations](https://longbridge.com/en/news/294368548.md) - [Cullinan Therapeutics (CGEM) Expected to Release Quarterly Earnings on Thursday](https://longbridge.com/en/news/294341758.md)